Although most substantial in the lungs, we observed organ‐wide occurrence of systemic inflammation in COVID‐19 represented by processes such as the complement cascade and interferon signaling and by central markers of inflammation such as the acute phase proteins CRP and LBP1. Here, UBP1 is linked to COVID-19.